Target intelligence / Profile preview

Plasmodium spp. heme detoxification pathway

Molecular classification
Metabolic pathway, Detoxification system, Other
01

Overview

The Plasmodium spp. heme detoxification pathway is a critical survival mechanism for malaria parasites during their intraerythrocytic stage. As the parasite digests host hemoglobin to obtain essential amino acids, it releases large amounts of toxic free heme, specifically ferriprotoporphyrin IX (Egan, 2008, Drug Design Reviews). To prevent cellular damage, the parasite detoxifies this heme by sequestering it into an insoluble, chemically inert crystalline form known as hemozoin or malaria pigment (Sullivan, 2002, International Journal for Parasitology). This biocrystallization process occurs primarily within the acidic digestive vacuole and is facilitated by parasite-encoded proteins like Heme Detoxification Protein (HDP) and various lipids (Jani et al., 2008, PLoS Pathogens). This pathway is the primary target for several classes of antimalarial drugs, most notably the 4-aminoquinolines like chloroquine, which bind to heme and prevent its incorporation into the growing hemozoin crystal (Combrinck et al., 2013, ACS Chemical Biology). The resulting buildup of free heme is lethal to the parasite, making this pathway one of the most successful targets in the history of antimalarial chemotherapy.

Other names
Hemozoin formation pathwayHeme biocrystallizationHeme polymerization pathwayMalaria pigment formationHeme detoxification system
02

Mechanism of action

Inhibition of the conversion of toxic free heme (ferriprotoporphyrin IX) into non-toxic, crystalline hemozoin within the parasite's digestive vacuole, leading to heme-mediated membrane damage and parasite death (Sullivan et al., 1996, Science).

03

Biological functions

Heme detoxificationHemozoin formationIron homeostasisHemoglobin catabolismCellular detoxification
04

Disease associations

InfectionMalaria
05

Safety considerations

Emergence of drug resistance via mutations in transporters like PfCRT (Fidock et al., 2000, Molecular Cell)Retinal toxicity associated with long-term quinoline useCardiovascular effects including QT prolongationNeuropsychiatric side effects associated with mefloquine
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin (malaria pigment)Plasmodium falciparum histidine-rich protein 2 (PfHRP2)Parasitemia levels

Beyond the preview

Go deeper on Plasmodium spp. heme detoxification pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium spp. heme detoxification pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call